Evidence map›Paper›PMID 15626643›Full record

ArticleEnvironmental health perspectives2005

Assessment of autoimmune responses associated with asbestos exposure in Libby, Montana, USA.

Jean C Pfau, Jami J Sentissi, Greg Weller, Elizabeth A Putnam

Open access · diamondAbstract read
In one paragraph

Article in Environmental health perspectives, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 1 pooled it
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 1 synthesis or guideline pooled it, 110 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Autoantibodies and cancer among asbestos-exposed cohorts in Western Australia.Journal of toxicology and environmental health. Part A · 2021
    Article
  9. Asbestos in High-Risk Communities: Public Health Implications.International journal of environmental research and public health · 2021
    Review
  10. Mechanisms of Environment-Induced Autoimmunity.Annual review of pharmacology and toxicology · 2021
    Article
  11. Asbestos exposure and autoantibody titers.Annals of occupational and environmental medicine · 2020
    Article
  12. Follow-Up of the Libby, Montana Screening Cohort: A 17-Year Mortality Study.Journal of occupational and environmental medicine · 2020
    Article
  13. Article
  14. Analysis of autoantibody profiles in two asbestiform fiber exposure cohorts.Journal of toxicology and environmental health. Part A · 2018
    Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Libby amphibole-induced mesothelial cell autoantibodies promote collagen deposition in mice.American journal of physiology. Lung cellular and molecular physiology · 2016
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Jean C PfauCenter for Environmental Health Sciences, Department of Biomedical and Pharmaceutical Sciences, University of Montana, Missoula, Montana 59812, USA. jean.pfau@umontana.edu
Jami J Sentissi
Greg Weller
Elizabeth A Putnam
Center for Environmental Health · US

Funding

SILICA AND ASBESTOS EFFECTS ON MACROPHAGE FUNCTIONR01ES004804 · NIEHS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI HOLIAN, ANDRIJ · 1989 to 2004
$1.1M
Investigations of Asbestos-Related DiseasesR21ES011676 · NIEHS · UNIVERSITY OF MONTANA · PI PUTNAM, ELIZABETH A · 2002 to 2004
$619k
Mechanism of Silica-Induced Autoimmune ResponsesF32ES011249 · NIEHS · UNIVERSITY OF MONTANA · PI PFAU, JEAN COOPER · 2001 to 2001
$42k
NIEHS NIH HHS ES-04804NIEHS NIH HHS ES-11249NIEHS NIH HHS ES-11676
6 · The paper itself

Abstract

Systemic autoimmune responses are associated with certain environmental exposures, including crystalline particles such as silica. Positive antinuclear antibody (ANA) tests have been reported in small cohorts exposed to asbestos, but many questions remain regarding the prevalence, pattern, and significance of autoantibodies associated with asbestos exposures. The population in Libby, Montana, provides a unique opportunity for such a study because of both occupational and environmental exposures that have occurred as a result of the mining of asbestos-contaminated vermiculite near the community. As part of a multifaceted assessment of the impact of asbestos exposures on this population, this study explored the possibility of exacerbated autoimmune responses. Age- and sex-matched sets of 50 serum samples from Libby and Missoula, Montana (unexposed), were tested for ANA on HEp-2 cells using indirect immunofluorescence. Data included frequency of positive tests, ANA titers, staining patterns, and scored fluorescence intensity, all against known controls. Serum immunoglobulin A (IgA), rheumatoid factor, and antibodies to extractable nuclear antigen (ENA) were also tested. The Libby samples showed significantly higher frequency of positive ANA and ENA tests, increased mean fluorescence intensity and titers of the ANAs, and higher serum IgA, compared with Missoula samples. In the Libby samples, positive correlations were found between ANA titers and both lung disease severity and extent of exposure. The results support the hypothesis that asbestos exposure is associated with autoimmune responses and suggests that a relationship exists between those responses and asbestos-related disease processes.

Indexed as

AutoimmunityEnvironmental ExposureOccupational ExposureAsbestosCarcinogensCase-Control StudiesCohort StudiesFemaleHumansImmunoglobulin AMaleMiddle AgedMiningMontanaAsbestosCarcinogensImmunoglobulin A

Identifiers

PMID15626643
PMCPMC1253705
OpenAlexW1977496118

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.